CDY 1.43% 7.1¢ cellmid limited

Ann: Significant New Findings Published on Midkine, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 673 Posts.
    lightbulb Created with Sketch. 54
    Yes great encouraging posts of Evolis in Pitt Street thanks gliontos. Despite that one great location exposure, the sales across Aus have been hopeless and disappointing to all including the CEO. MH said in the last report they intend to do better ( but when, how and with what money) .

    That presumably means they intend one day to support Aus retail outlets which they’ve strangely ignored so far. With ~1,800 Aus pharmacies stocking Evolis the last time we were told the number, but no update in several years that I’ve seen, the annual sales from that sector of <$800,000 max as far as I can guess (given the secrecy and lack of information from MH on most things including Aus sales etc. etc.), indicates the average monthly sales per Aus pharmacy of $40.

    Those estimates point to an average of 2 buying customers per Aus pharmacy per year. CEO please explain.
    ,
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.